India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
Alankit will undertake the verification of pending e-KYC enrollments through the Beneficiary Identification System (BIS) platform provided by the National Health Authority (NHA).
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as to create a talented workforce for the Fourth Industrial Revolution
GEMTESA is the first and only beta-3 agonist approved for the treatment of men with OAB symptoms who are receiving pharmacological therapy for BPH
JCI accreditation is recognized globally
The technical program will run in four sessions and a panel discussion on “Challenges in translation of medical technologies”
Exploring new opportunities within the fast-growing market of microfluidics
This facility marks a significant milestone in transforming the global food industr
The TGA approval marks a pivotal step in Rusan Pharma’s expansion into the Australian market
Subscribe To Our Newsletter & Stay Updated
